4896.T
K Pharma,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 799.00
+0.88%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- -9.6%
- EPS
- -17.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- -14.5%
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- -9.6%
- Net income
- -17.4%
- EPS
- -17.3%
- Free cash flow
- +6.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026